Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Plos One|December 11, 2012
Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatmentSilje Skrede, Johan Fernø, Bodil Bjørndal, et al.
Stem Cell Research|October 16, 2015
The cytokine-mediated crosstalk between primary human acute myeloid cells and mesenchymal stem cells alters the local cytokine network and the global gene expression profile of the mesenchymal cellsHåkon Reikvam, Annette K Brenner, Karen Marie Hagen, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 6, 2016
Genetic evidence for a role of the SREBP transcription system and lipid biosynthesis in schizophrenia and antipsychotic treatmentVidar M Steen, Silje Skrede, Tatiana Polushina, et al.
British Journal of Haematology|January 4, 2014
Antileukaemic effect of PI3K-mTOR inhibitors in acute myeloid leukaemia-gene expression profiles reveal CDC25B expression as determinate of pharmacological effectHåkon Reikvam, Jerome Tamburini, Silje Skrede, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 28, 2024
Potent synergistic effects of dulaglutide and food restriction in prevention of olanzapine-induced metabolic adverse effects in a rodent modelKaterina Horska, Jan Kucera, Eva Drazanova, et al.
The International Journal of Neuropsychopharmacology|March 12, 2019
One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic EffectsKari M Ersland, Lene S Myrmel, Even Fjære, et al.
Frontiers in Psychiatry|February 20, 2014
A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammationRune A Kroken, Else-Marie Løberg, Tore Drønen, et al.
Plos One|November 19, 2013
Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1Vidar M Steen, Chirag Nepal, Kari M Ersland, et al.
Basic & Clinical Pharmacology & Toxicology|October 6, 2025
Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An UpdateJames Bluett, Merita Rumano, María José Martínez Becerra, et al.
Plos One|June 23, 2011
Olanzapine-induced hyperphagia and weight gain associate with orexigenic hypothalamic neuropeptide signaling without concomitant AMPK phosphorylationJohan Fernø, Luis Varela, Silje Skrede, et al.
Pageof 6